Refine
Has Fulltext
- yes (122)
Is part of the Bibliography
- yes (122)
Year of publication
Document Type
- Journal article (85)
- Doctoral Thesis (36)
- Preprint (1)
Language
- English (122) (remove)
Keywords
- melt electrowriting (13)
- 3D printing (12)
- additive manufacturing (10)
- biofabrication (9)
- hyaluronic acid (7)
- melt electrospinning writing (7)
- Hydrogel (6)
- bioprinting (6)
- 3D-Druck (5)
- bioink (5)
- polycaprolactone (5)
- tissue engineering (5)
- Polymere (4)
- Tissue Engineering (4)
- hydrogel (4)
- hydrogels (4)
- magnesium phosphate cement (4)
- phytic acid (4)
- scaffold (4)
- thiol-ene (4)
- Biofabrication (3)
- Biomaterial (3)
- Calciumphosphate (3)
- Knochenzement (3)
- biomaterials (3)
- bone (3)
- breast cancer (3)
- calcium phosphate cement (3)
- chondrogenic differentiation (3)
- electrohydrodynamics (3)
- extracellular matrix (3)
- melt electrowriting (MEW) (3)
- 3D powder printing (2)
- Calciumphosphat (2)
- Cement (2)
- Dihydrooxazole (2)
- Electrospinning (2)
- Fluorescence Microscopy (2)
- Knochenersatz (2)
- MSC (2)
- Melt Electrowriting (2)
- Melt electrowriting (2)
- Nanopartikel (2)
- Oberflächenfunktionalisierung (2)
- Polyethylenglykole (2)
- Polyoxazoline (2)
- Ringöffnungspolymerisation (2)
- Tissue engineering (2)
- Zement (2)
- angiogenesis (2)
- arteriovenous loop (2)
- baghdadite (2)
- biocompatibility (2)
- biomedical materials (2)
- bone adhesive (2)
- bone cement (2)
- calcium phosphate (2)
- cartilage (2)
- cortical neurons (2)
- dual setting (2)
- dual setting system (2)
- dual-stage crosslinking (2)
- electrohydrodynamic (2)
- in vitro (2)
- inflammation (2)
- polymer processing (2)
- polymer-peptide-conjugate (2)
- printability (2)
- rheology (2)
- shape fidelity (2)
- therapy (2)
- (AB)\(_{n}\) segmented copolymers (1)
- 2-Aminoethylphosphonic acid (1)
- 316L stainless-steel (1)
- 3D Bioprinting (1)
- 3D Printing (1)
- 3D cultures (1)
- 3D electrophysiology (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D neuronal networks (1)
- 3D scaffolds (1)
- 3D tumor model (1)
- ACPC (1)
- ALI culture (1)
- Additive Fertigung (1)
- Adenovirus (1)
- Adhäsion (1)
- Adipose Tissue (1)
- Anisotropic structures (1)
- Arteriosklerose (1)
- Artery Models (1)
- Aspergillose (1)
- Aspergillosis (1)
- Atherosclerosis (1)
- Baghdadite (1)
- Beschichtung (1)
- Biofabrication of hydrogels (1)
- Biofabrikation (1)
- Bioink (1)
- Biologischer Abbau (1)
- Blockcopolymere (1)
- Bone marrow (1)
- Bone-replacement (1)
- Breast cancer (1)
- Ca\(^{2+}\)-Imaging (1)
- Calcium Phosphate (1)
- Calcium phosphate (1)
- Calcium phosphate-based biomaterials (1)
- Calciumhydroxid (1)
- Calciumphosphatzemente (1)
- Cartilage (1)
- Cell Sheet Engineering (1)
- Cell adhesion (1)
- Ceramic polymer composite (1)
- Chelatbildner (1)
- Chemical modification of biopolymers (1)
- Chondrogenesis (1)
- Chondrogenic differentiation (1)
- Chondrozyten (1)
- Colloidal Stability (1)
- Correlative microscopy (1)
- Dectin-1 (1)
- Degradation (1)
- Dual setting system (1)
- Dual-setting (1)
- ECM (1)
- Elektrospinnen (1)
- Elektrostatisches Verspinnen (1)
- Extrazelluläre Matrix (1)
- Fettgewebe (1)
- Fibrin (1)
- Fibroblasten (1)
- FluidFM (1)
- FluidFM technology (1)
- Freezing (1)
- Functional hydrophilic polymers (1)
- Funktionalisierung <Chemie> (1)
- Funktionalisierung von elektrogesponnenen Fasern (1)
- Gefrierstrukturierung (1)
- Gelatine (1)
- Gene therapy (1)
- Gerichtete Erstarrung (1)
- Gewebe (1)
- Geweberegeneration (1)
- Glycidol (1)
- Gold-Nanoparticles (1)
- HA modifiedCNF membranes (1)
- HASH (1)
- HEMA (1)
- Hemodynamics (1)
- Hyaluronic Acid (1)
- Hyaluronsäure (1)
- Hypertrophy (1)
- Hämodynamik (1)
- IP6 (1)
- Implantat (1)
- In vitro model (1)
- Injectability (1)
- Iron Oxide Nanoparticles (1)
- Isocyanate (1)
- Janus fibers (1)
- Knochen (1)
- Knochenkleber (1)
- Knochenwachs (1)
- Knochenzemente (1)
- Knorpel (1)
- Konjugate (1)
- Korrelative Mikroskopie (1)
- MPI (1)
- MPS (1)
- MRI (1)
- Macrophage extracellular traps (1)
- Magnesiumphosphate (1)
- Makrophagen (1)
- Melt electrospinning (1)
- Mesenchymal stem cell (1)
- Modification (1)
- Modifikation von Biokeramiken (1)
- Morphology (1)
- Multifunctionalisability (1)
- NCO-sP(EO-stat-PO) (1)
- NLRP3 (1)
- Nanofaser (1)
- Nanogels (1)
- Nanoröhre (1)
- Nanotubular coatings (1)
- Nanotubuläre Beschichtungen (1)
- Normal breast (1)
- Oxygen diffusion hardening (1)
- PCL (1)
- PEG (1)
- PLGA (1)
- PTEN (1)
- PVD Beschichtung (1)
- PVD coatings (1)
- PVD-Verfahren (1)
- Poly(2-oxazoline) (1)
- Poly(glycidol)s (1)
- Polycaprolacton (1)
- Polylactid-co-Glycolid (1)
- Polymer-peptide-conjugate (1)
- Polymers (1)
- Polymilchsäure (1)
- Polyoxazolines (1)
- Primary cell lines (1)
- QCM (1)
- RAFT (1)
- RHO (1)
- ROCK (1)
- Rapid Prototyping <Fertigung> (1)
- Regeneration (1)
- Rheology (1)
- SOX9 (1)
- Sauerstoffdiffusionshärtung (1)
- Scaffold (1)
- Scaffold <Tissue Engineering> (1)
- Schiff base chemistry (1)
- Schleuderguss (1)
- Setting Control (1)
- Silica precursor (1)
- Sol-gel (1)
- Staphylococcus aureus / drug effects (1)
- Star-shaped poly(ethylene glycol) (1)
- Stem cells plasticity (1)
- Sternpolymere (1)
- Tantal (1)
- Therapeutisches System (1)
- Thermoresponsive Polymere (1)
- Thioether-Poly(glycidol) (1)
- Ti(Ag) Beschichtungen (1)
- Ti(Ag) coatings (1)
- Unidirectional Freezing (1)
- Vancomycin / administration & dosage (1)
- Vancomycin / chemistry (1)
- Vancomycin / pharmacology (1)
- Vascularization (1)
- Vaskularisation (1)
- Verbundwerkstoff (1)
- WST test (1)
- Wasserlösliche Polymere (1)
- Wirkstoff-Träger-System (1)
- Wirkstofffreisetzung (1)
- ZIP (1)
- acrylate-endcapped urethane-based polymer (AUP) (1)
- actin (1)
- acute myeloid leukaemia (1)
- adhesion dynamics (1)
- adipose tissue (1)
- adipose-derived stromal cells (1)
- agarose (1)
- alginate (1)
- alveolar‐capillary barrier (1)
- amoeboid cell migration (1)
- animal model (1)
- anisotropic porous structures (1)
- anti-bacterial agents / administration & dosage (1)
- anti-bacterial agents / chemistry (1)
- anti-bacterial agents / pharmacology (1)
- antibacterial (1)
- antibakteriell (1)
- arthritis (1)
- artificial bones (1)
- astrocytes (1)
- atomic force microscopy (1)
- axial vascularization (1)
- azlactone (1)
- balloon kyphoplasty (1)
- bending strength (1)
- bio-printability (1)
- bioceramic (1)
- bioceramics (1)
- biocompatible Materials (1)
- biodegradable polymer (1)
- biodegradable polymers (1)
- biofabricated vascular graft (1)
- bioinorganic (1)
- bioinspired interface (1)
- bioinspired membrane (1)
- biological models (1)
- biomaterial ink (1)
- biomechanical evaluation (1)
- biomechanics (1)
- biomedical engineering (1)
- biophysics (1)
- biosensor (1)
- biosensors (1)
- blood-plasma (1)
- bohrbar (1)
- bone and cartilage tissue engineering (1)
- bone critical size defect (1)
- bone graft substitutes (1)
- bone replacement material (1)
- bone wax (1)
- bone wires (1)
- brain cancer (1)
- breast cancer model (1)
- brushite cement (1)
- calcaneus (1)
- calcium phosphate cements (1)
- calcium-phosphate (1)
- calciumhydroxide (1)
- carbon fiber reinforcement (1)
- cardiovascular pharmacology (1)
- cartilage repair (1)
- cell coagulation (1)
- cell counting (1)
- cell elongation (1)
- cell guidance (1)
- cell migration (1)
- cell morphology (1)
- cell printing (1)
- cell self-assembled monolayers (1)
- cell transplantation (1)
- cell viability (1)
- cement (1)
- centrifugally casting (1)
- ceramic polymer composite (1)
- ceramics (1)
- chemical crosslinking (1)
- chemokines (1)
- chemoselective (1)
- chemosensitivity (1)
- chondrocyte (1)
- chondrocytes (1)
- chondroprogenitors (1)
- click chemistry (1)
- co-culture (1)
- coating (1)
- coatings (1)
- cochlea (1)
- collagen (1)
- collagen sponge (1)
- combination of physical vapor deposition and electrochemical etching (1)
- composite material (1)
- compressive strength (1)
- connective tissue (1)
- crosslinked coating (1)
- cryostructured scaffolds (1)
- cyclic mechanical stretch (1)
- cyclic stretch (1)
- cyclic testing (1)
- cyto-compatibility (1)
- cytotoxicity (1)
- damage tolerant cement (1)
- deafness (1)
- defects (1)
- defined humanized test system (1)
- definition (1)
- degradable bone substitutes (1)
- degradable implant (1)
- degradation (1)
- detachment force quantification (1)
- dicalcium phosphate cement (1)
- differentation (1)
- digitization (1)
- dihydrate cement (1)
- directional solidification (1)
- disease models (1)
- drillability (1)
- drillable (1)
- drillable bone cement (1)
- drop on demand (1)
- drug delivery (1)
- drug liberation (1)
- drug release (1)
- dual abbindend (1)
- durotaxis (1)
- electroactive (1)
- electroactive polymers (1)
- electron microscopy (1)
- electrospinning (1)
- electrospun fibers (1)
- eletrhydrodynamic (1)
- embedded templating (1)
- endothelial progenitor cells (1)
- expression (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- extrusion-based 3D printing (1)
- factor-I (1)
- farringtonite (1)
- fiber (1)
- fiber reinforcement (1)
- fibers (1)
- fiber–matrix interaction (1)
- fixation (1)
- focal adhesions (1)
- force (1)
- fracture (1)
- free radical polymerization (1)
- functionalization (1)
- funktionale Präpolymere (1)
- gels (1)
- gels and hydrogels (1)
- gentamicin-loaded poly (methyl methacrylate) bone cement (1)
- granules (1)
- growth (1)
- guided bone regeneration (1)
- heart-failure (1)
- hemocompatibility (1)
- heterotypic scaffold design (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human macrophages (1)
- human neutrophil elastase (HNE) (1)
- hybrid fabrication (1)
- hybrid materials (1)
- hybrid polymers (1)
- hydraulic reactivity (1)
- hydrogel formation (1)
- hydrophilic polymers (1)
- hydroxyapatite (1)
- hypoxia (1)
- imaging agents (1)
- immunomodulation (1)
- implant (1)
- implants (1)
- in vitro cell‐stretch model (1)
- in-vivo Micro-Computed Tomography (1)
- inflammatory response (1)
- inner ear (1)
- inositol hexaphosphate (1)
- intercellular adhesion (1)
- interface control (1)
- iron release (1)
- lectin (1)
- left-ventricular function (1)
- load to failure testing (1)
- lung cell model (1)
- macrophage polarization (1)
- macrophages (1)
- magnetic properties (1)
- magnetoactive materials (1)
- materials testing (1)
- mature cell-cell contacts (1)
- mechanical activation (1)
- mechanical performance (1)
- mechanical properties (1)
- mechanical reinforcement (1)
- medical device (1)
- medical-grade poly(ε-caprolactone) (1)
- medicine (1)
- melanoma (1)
- melt electrowriting (1)
- melt electrofibrillation (1)
- melt electrospinning (1)
- mesenchymal stem cells (1)
- microfibers (1)
- microfibres (1)
- microfluidics (1)
- microstructures (1)
- microvasculature (1)
- migration (1)
- minipig (1)
- modelling (1)
- morphology controls (1)
- mucin (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- nanofibers (1)
- nanostructures (1)
- nanotopographical surfaces (1)
- native chemical ligation (1)
- networks (1)
- neurite growth (1)
- organ-on-a-chip (1)
- organoids (1)
- osseointegration (1)
- osteoblasts (1)
- osteochondral defect (1)
- osteoporosis (1)
- oxidation (1)
- particle study (1)
- peptide conjugation (1)
- peptide immobilization (1)
- phase conversion (1)
- photo-crosslinking (1)
- photopolymerization (1)
- physicochemical characterization (1)
- plasticizers (1)
- platelet-adhesion (1)
- platelets (1)
- poly(2-ethyl-2-oxazoline) (1)
- poly(2-oxazoline)s (1)
- poly(ethylene glycol) (1)
- poly(glycidol) (1)
- poly(lactic-co-glycolic acid) (1)
- poly(lactide-co-glycolide) (1)
- polyacrylic acid (1)
- polyethylene glycol (1)
- polyethylenglykole (1)
- polyglycidol (1)
- polylactid (1)
- polymer (1)
- polymer-analogue functionalization (1)
- polymeric matrix (1)
- polymers (1)
- polyoxazoline (1)
- polyoxazolines (1)
- porosity (1)
- postsurgical adhesion (1)
- pre-crosslinking (1)
- premixed (1)
- primary vascular smooth muscle‐like cells (vSMCs) (1)
- proliferation (1)
- prostheses and implants (1)
- protein adsorption (1)
- präfabriziert (1)
- radiopacity (1)
- rat model (1)
- recruitment (1)
- remodelling (1)
- repair (1)
- rhBMP–2 (1)
- ring opening polymerisation (1)
- ring-opening polymerization (1)
- sPEG (1)
- sacrificial printing (1)
- sanders (1)
- scaffolds (1)
- screw (1)
- self-assembled monolayers (1)
- serial block face EM (1)
- setting reaction (1)
- shear stress (1)
- shear thinning (1)
- signaling (1)
- silicones (1)
- sodium alginate (1)
- solution electrospinning (1)
- spheroids (1)
- spinning (1)
- stanfieldite (1)
- starPEG (1)
- starPEG hydrogel (1)
- stem cells (1)
- stimulation (1)
- stress (1)
- subcutaneous implanation (1)
- sugar glass printing (1)
- surface coating (1)
- surface functionalisation (1)
- surface functionalization (1)
- surfaces (1)
- sutures (1)
- synbones (1)
- synergistic reinforcement (1)
- synthetic hydrogels (1)
- systematic investigations (1)
- tension (1)
- tethering (1)
- thermoresponsive hydrogel (1)
- thrombin (1)
- thrombosis (1)
- tibial head depression fracture (1)
- tissue morphogenesis (1)
- tissue regeneration (1)
- topotaxis (1)
- total joint arthroplasty (1)
- total knee arthroplasty (1)
- traction (1)
- tranexamic acid (1)
- transforming growth factor-beta 1 (1)
- transplantation (1)
- tubular constructs (1)
- tumor heterogeneity (1)
- tunable ultra‐thin biphasic membrane (1)
- unidirectional freezing (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- x-ray micro computed tomography (1)
- zinc (1)
- zonal (1)
- zonal construct (1)
- α-tricalcium phosphate (1)
Institute
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (122) (remove)
Sonstige beteiligte Institutionen
In order to mimic the extracellular matrix for tissue engineering, recent research approaches often involve 3D printing or electrospinning of fibres to scaffolds as cell carrier material. Within this thesis, a micron fibre printing process, called melt electrospinning writing (MEW), combining both additive manufacturing and electrospinning, has been investigated and improved. Thus, a unique device was developed for accurate process control and manufacturing of high quality constructs. Thereby, different studies could be conducted in order to understand the electrohydrodynamic printing behaviour of different medically relevant thermoplastics as well as to characterise the influence of MEW on the resulting scaffold performance.
For reproducible scaffold printing, a commonly occurring processing instability was investigated and defined as pulsing, or in extreme cases as long beading. Here, processing analysis could be performed with the aim to overcome those instabilities and prevent the resulting manufacturing issues. Two different biocompatible polymers were utilised for this study: poly(ε-caprolactone) (PCL) as the only material available for MEW until then and poly(2-ethyl-2-oxazoline) for the first time. A hypothesis including the dependency of pulsing regarding involved mass flows regulated by the feeding pressure and the electrical field strength could be presented. Further, a guide via fibre diameter quantification was established to assess and accomplish high quality printing of scaffolds for subsequent research tasks.
By following a combined approach including small sized spinnerets, small flow rates and high field strengths, PCL fibres with submicron-sized fibre diameters (fØ = 817 ± 165 nm) were deposited to defined scaffolds. The resulting material characteristics could be investigated regarding molecular orientation and morphological aspects. Thereby, an alignment and isotropic crystallinity was observed that can be attributed to the distinct acceleration of the solidifying jet in the electrical field and by the collector uptake. Resulting submicron fibres formed accurate but mechanically sensitive structures requiring further preparation for a suitable use in cell biology. To overcome this handling issue, a coating procedure, by using hydrophilic and cross-linkable star-shaped molecules for preparing fibre adhesive but cell repellent collector surfaces, was used.
Printing PCL fibre patterns below the critical translation speed (CTS) revealed the opportunity to manufacture sinusoidal shaped fibres analogously to those observed using purely viscous fluids falling on a moving belt. No significant influence of the high voltage field during MEW processing could be observed on the buckling phenomenon. A study on the sinusoidal geometry revealed increasing peak-to-peak values and decreasing wavelengths as a function of decreasing collector speeds sc between CTS > sc ≥ 2/3 CTS independent of feeding pressures. Resulting scaffolds printed at 100 %, 90 %, 80 % and 70 % of CTS exhibited significantly different tensile properties, foremost regarding Young’s moduli (E = 42 ± 7 MPa to 173 ± 22 MPa at 1 – 3 % strain). As known from literature, a changed morphology and mechanical environment can impact cell performance substantially leading to a new opportunity of tailoring TE scaffolds.
Further, poly(L-lactide-co-ε-caprolactone-co-acryloyl carbonate) as well as poly(ε-caprolactone-co-acryloyl carbonate) (PCLAC) copolymers could be used for MEW printing. Those exhibit the opportunity for UV-initiated radical cross-linking in a post-processing step leading to significantly increased mechanical characteristics. Here, single fibres of the polymer composed of 90 mol.% CL and 10 mol.% AC showed a considerable maximum tensile strength of σmax = 53 ± 16 MPa. Furthermore, sinusoidal meanders made of PCLAC yielded a specific tensile stress-strain characteristic mimicking the qualitative behaviour of tendons or ligaments. Cell viability by L929 murine fibroblasts and live/dead staining with human mesenchymal stem cells revealed a promising biomaterial behaviour pointing out MEW printed PCLAC scaffolds as promising choice for medical repair of load-bearing soft tissue.
Indeed, one apparent drawback, the small throughput similar to other AM methods, may still prevent MEW’s industrial application yet. However, ongoing research focusses on enlargement of manufacturing speed with the clear perspective of relevant improvement. Thereby, the utilisation of large spinneret sizes may enable printing of high volume rates, while downsizing the resulting fibre diameter via electrical field and mechanical stretching by the collector uptake. Using this approach, limitations of FDM by small nozzle sizes could be overcome. Thinking visionary, such printing devices could be placed in hospitals for patient-specific printing-on-demand therapies one day. Taking the evolved high deposition precision combined with the unique small fibre diameter sizes into account, technical processing of high performance membranes, filters or functional surface finishes also stands to reason.
Animal models are important tools to investigate the pathogenesis and develop treatment strategies for breast cancer in humans. In this study, we developed a new three-dimensional in vivo arteriovenous loop model of human breast cancer with the aid of biodegradable materials, including fibrin, alginate, and polycaprolactone. We examined the in vivo effects of various matrices on the growth of breast cancer cells by imaging and immunohistochemistry evaluation. Our findings clearly demonstrate that vascularized breast cancer microtissues could be engineered and recapitulate the in vivo situation and tumor-stromal interaction within an isolated environment in an in vivo organism. Alginate–fibrin hybrid matrices were considered as a highly powerful material for breast tumor engineering based on its stability and biocompatibility. We propose that the novel tumor model may not only serve as an invaluable platform for analyzing and understanding the molecular mechanisms and pattern of oncologic diseases, but also be tailored for individual therapy via transplantation of breast cancer patient-derived tumors.
In the treatment of bone non-unions, an alternative to bone autografts is the use of bone morphogenetic proteins (BMPs), e.g., BMP–2, BMP–7, with powerful osteoinductive and osteogenic properties. In clinical settings, these osteogenic factors are applied using absorbable collagen sponges for local controlled delivery. Major side effects of this strategy are derived from the supraphysiological doses of BMPs needed, which may induce ectopic bone formation, chronic inflammation, and excessive bone resorption. In order to increase the efficiency of the delivered BMPs, we designed cryostructured collagen scaffolds functionalized with hydroxyapatite, mimicking the structure of cortical bone (aligned porosity, anisotropic) or trabecular bone (random distributed porosity, isotropic). We hypothesize that an anisotropic structure would enhance the osteoconductive properties of the scaffolds by increasing the regenerative performance of the provided rhBMP–2. In vitro, both scaffolds presented similar mechanical properties, rhBMP–2 retention and delivery capacity, as well as scaffold degradation time. In vivo, anisotropic scaffolds demonstrated better bone regeneration capabilities in a rat femoral critical-size defect model by increasing the defect bridging. In conclusion, anisotropic cryostructured collagen scaffolds improve bone regeneration by increasing the efficiency of rhBMP–2 mediated bone healing.
Biointerface engineering is a wide-spread strategy to improve the healing process and subsequent tissue integration of biomaterials. Especially the integration of specific peptides is one promising strategy to promote the regenerative capacity of implants and 3D scaffolds. In vivo, these tailored interfaces are, however, first confronted with the innate immune response. Neutrophils are cells with pronounced proteolytic potential and the first recruited immune cells at the implant site; nonetheless, they have so far been underappreciated in the design of biomaterial interfaces. Herein, an in vitro approach is introduced to model and analyze the neutrophil interaction with bioactivated materials at the example of nano-bioinspired electrospun surfaces that reveals the vulnerability of a given biointerface design to the contact with neutrophils. A sacrificial, transient hydrogel coating that demonstrates optimal protection for peptide-modified surfaces and thus alleviates the immediate cleavage by neutrophil elastase is further introduced.
Bioactive glass (BG) scaffolds are being investigated for bone tissue engineering applications because of their osteoconductive and angiogenic nature. However, to increase the in vivo performance of the scaffold, including enhancing the angiogenetic growth into the scaffolds, some researchers use different modifications of the scaffold including addition of inorganic ionic components to the basic BG composition. In this study, we investigated the in vitro biocompatibility and bioactivity of Cu2+-doped BG derived scaffolds in either BMSC (bone-marrow derived mesenchymal stem cells)-only culture or co-culture of BMSC and human dermal microvascular endothelial cells (HDMEC). In BMSC-only culture, cells were seeded either directly on the scaffolds (3D or direct culture) or were exposed to ionic dissolution products of the BG scaffolds, kept in permeable cell culture inserts (2D or indirect culture). Though we did not observe any direct osteoinduction of BMSCs by alkaline phosphatase (ALP) assay or by PCR, there was increased vascular endothelial growth factor (VEGF) expression, observed by PCR and ELISA assays. Additionally, the scaffolds showed no toxicity to BMSCs and there were healthy live cells found throughout the scaffold. To analyze further the reasons behind the increased VEGF expression and to exploit the benefits of the finding, we used the indirect method with HDMECs in culture plastic and Cu2+-doped BG scaffolds with or without BMSCs in cell culture inserts. There was clear observation of increased endothelial markers by both FACS analysis and acetylated LDL (acLDL) uptake assay. Only in presence of Cu2+-doped BG scaffolds with BMSCs, a high VEGF secretion was demonstrated by ELISA; and typical tubular structures were observed in culture plastics. We conclude that Cu2+-doped BG scaffolds release Cu2+, which in turn act on BMSCs to secrete VEGF. This result is of significance for the application of BG scaffolds in bone tissue engineering approaches.
Intraperitoneal adhesions are fibrous bands that connect tissues in the peritoneal cavity that are usually separated. These adhesions form as a consequence of trauma, inflammation or surgical interventions and often result in severe consequences such as chronic pain, small bowel obstructions or female infertility.
The aim of this thesis was to develop a synthetic barrier device for adhesion prevention made of modified poly(lactide) [PLA]. Solid PLA films (SurgiWrap®) are already successfully in clinical use due to the good biocompatibility and the biodegradability of the material resulting in non-toxic degradation products since lactic acid is naturally part of the metabolic circles of the human body. Considering the brittleness and stiffness of the films, the long degradation time of several months as well as the need for suturing, there is potential for optimization. Through a copolymerization with the hydrophilic poly(ethylene glycol) [PEG], a reduction of the degradation time was intendend. Moreover, the copolymerization should also lead to an improvement of the mechanical properties of the films since PEG acts as plasticizer for PLA. Linear PLA-PEG-PLA triblock copolymers as well as star-shaped PEG-PLA copolymers were synthesized via standard ring opening polymerization to tailor the barrier properties. Besides solid films, solution electrospun meshes from PLA and the synthesized PEG-PLA copolymers were investigated for a potential application as well. Since suturing of a barrier additionally induces adhesion formation, alginate coated membranes were prepared in order to achieve self-adhesiveness. With the intention to reduce infections and consequently inflammation, electrospun meshes and solvent cast films were loaded with the antibacterial drug triclosan and drug release as well as antibacterial efficacy was investigated.
Mechanical tests confirmed that through the variation of the PEG content and branching the mechanical properties can be tailored and are in good accordance with the glass transition temperatures [Tg] of the polymers. Consequently, potentially adequate mechanical properties for surgical handling as well as for the performance within the patient’s body were successfully achieved. Degradation studies revealed that the degradation time was significantly shorter for PEG-PLA membranes than for PLA films and with an appropriate PEG content could be adjusted to the intended time frame. Cell adhesion and viability tests confirmed the non-toxicity of the clinically used PLA films as well as of PEG-PLA films and meshes. With a bioadhesion test the benefit of an alginate coated side towards the pure PLA film concerning self-adhesiveness was successfully demonstrated. Moreover, optical evaluations and a T-peel test of different alginate coated PLA films showed that the cohesion between the chemically different layers was distinctly enhanced by the use of an appropriate PEG-PLA mesh as intermediate cohesion promoting layer. In in vitro release studies with triclosan loaded films a higher release was determined for PEG-PLA than for PLA films. In agar diffusion tests a higher and longer inhibition of staphylococcus aureus growth was observed confirming the release results. Moreover, drug loaded meshes (especially drug loaded after electrospinning) showed enhanced and elongated bacterial inhibition in comparison to films.
3D bioprinting often involves application of highly concentrated polymeric bioinks to enable fabrication of stable cell-hydrogel constructs, although poor cell survival, compromised stem cell differentiation, and an inhomogeneous distribution of newly produced extracellular matrix (ECM) are frequently observed. Therefore, this study presents a bioink platform using a new versatile dual-stage crosslinking approach based on thiolated hyaluronic acid (HA-SH), which not only provides stand-alone 3D printability but also facilitates effective chondrogenic differentiation of mesenchymal stromal cells. A range of HA-SH with different molecular weights is synthesized and crosslinked with acrylated (PEG-diacryl) and allylated (PEG-diallyl) polyethylene glycol in a two-step reaction scheme. The initial Michael addition is used to achieve ink printability, followed by UV-mediated thiol–ene reaction to stabilize the printed bioink for long-term cell culture. Bioinks with high molecular weight HA-SH (>200 kDa) require comparably low polymer content to facilitate bioprinting. This leads to superior quality of cartilaginous constructs which possess a coherent ECM and a strongly increased stiffness of long-term cultured constructs. The dual-stage system may serve as an example to design platforms using two independent crosslinking reactions at one functional group, which allows adjusting printability as well as material and biological properties of bioinks.
Biomimetic calcium phosphate (CaP) coatings imitate the trabecular bones surface structure and have shown to promote osteogenic differentiation in multipotent cells. The work of this thesis focused on the problem of former CaP coatings cracking and flaking off when being put on a bendable core structure like a 3D-printed poly (ε-caprolactone) (PCL) scaffold. The aim was to provide a chemical linkage between PCL and CaP using a star-shaped polymer (sPEG) and a phosphonate, 2-aminoethylphosphonic acid (2-AEP). First, a published CaP coating protocol was revised and investigated in terms of etching parameters for the PCL scaffold. Results presented reproducible thick coatings for all groups. The protocol was then broadened to include subsequent scaffold incubation in sPEG and 2-AEP solutions. Homogenous CaP coatings of decreased thickness presented themselves, proving feasibility. However, as is often found with physical CaP coating depositions, there were some irregular outcomes even during the same experimental group. A lower consumption of the chemical 2-AEP, for economic reasons, meant that the protocol was altered to simultaneously incubate scaffolds with sPEG and 2-AEP including preceding calculations for molar ratios. For ratios 1:1, 1:2 and 1:3, again a homogenous CaP coating was produced on most of the samples, although reproducibility issues maintained. However, the mechanical bending to induce surface cracking showed that the CaP did strongly bond to the sPEG/2-AEP, while the control CaP coating flaked off the surface in large pieces. This research demonstrates that chemically-bound CaP coatings resist flaking off the fiber surface. Future investigations should focus on the mechanisms of CaP crystallization, to improve reproducibility.
Biofabrication, including printing technologies, has emerged as a powerful approach to the design of disease models, such as in cancer research. In breast cancer, adipose tissue has been acknowledged as an important part of the tumor microenvironment favoring tumor progression. Therefore, in this study, a 3D-printed breast cancer model for facilitating investigations into cancer cell-adipocyte interaction was developed. First, we focused on the printability of human adipose-derived stromal cell (ASC) spheroids in an extrusion-based bioprinting setup and the adipogenic differentiation within printed spheroids into adipose microtissues. The printing process was optimized in terms of spheroid viability and homogeneous spheroid distribution in a hyaluronic acid-based bioink. Adipogenic differentiation after printing was demonstrated by lipid accumulation, expression of adipogenic marker genes, and an adipogenic ECM profile. Subsequently, a breast cancer cell (MDA-MB-231) compartment was printed onto the adipose tissue constructs. After nine days of co-culture, we observed a cancer cell-induced reduction of the lipid content and a remodeling of the ECM within the adipose tissues, with increased fibronectin, collagen I and collagen VI expression. Together, our data demonstrate that 3D-printed breast cancer-adipose tissue models can recapitulate important aspects of the complex cell–cell and cell–matrix interplay within the tumor-stroma microenvironment
Background: Glioblastoma multiforme (GBM) and metastatic triple-negative breast cancer (TNBC) with PTEN mutations often lead to brain dissemination with poor patient outcome, thus new therapeutic targets are needed. To understand signaling, controlling the dynamics and mechanics of brain tumor cell migration, we implemented GBM and TNBC cell lines and designed 3D aligned microfibers and scaffolds mimicking brain structures. Methods: 3D microfibers and scaffolds were printed using melt electrowriting. GBM and TNBC cell lines with opposing PTEN genotypes were analyzed with RHO-ROCK-PTEN inhibitors and PTEN rescue using live-cell imaging. RNA-sequencing and qPCR of tumor cells in 3D with microfibers were performed, while scanning electron microscopy and confocal microscopy addressed cell morphology. Results: In contrast to the PTEN wildtype, GBM and TNBC cells with PTEN loss of function yielded enhanced durotaxis, topotaxis, adhesion, amoeboid migration on 3D microfibers and significant high RHOB expression. Functional studies concerning RHOB-ROCK-PTEN signaling confirmed the essential role for the above cellular processes. Conclusions: This study demonstrates a significant role of the PTEN genotype and RHOB expression for durotaxis, adhesion and migration dependent on 3D. GBM and TNBC cells with PTEN loss of function have an affinity for stiff brain structures promoting metastasis. 3D microfibers represent an important tool to model brain metastasizing tumor cells, where RHO-inhibitors could play an essential role for improved therapy.